Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Parkwalk Innovations EIS Fund is a specialized investment vehicle managed by Parkwalk Advisors, the UK's most active EIS fund manager focusing on university spin-outs. The fund invests in high-growth, R&D-intensive companies originating from the UK’s leading academic institutions, with a heavy concentration in life sciences, digital health, and deep technology. By leveraging the Enterprise Investment Scheme (EIS), the fund provides tax-efficient capital to early-stage ventures transitioning from the laboratory to commercialization. Its portfolio includes numerous biotech and medtech companies developing novel therapeutics, diagnostics, and medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovations EIS Fund.